Cover Image
市場調查報告書

血紅素檢驗的全球市場:2016∼2020年

Global Hemoglobin Testing Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361429
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
血紅素檢驗的全球市場:2016∼2020年 Global Hemoglobin Testing Market 2016-2020
出版日期: 2016年06月08日 內容資訊: 英文 73 Pages
簡介

根據調查,估計2015年,全球4億有1,600萬人患糖尿病病。貧血和糖尿病沒直接關係,不過,在本調查糖尿病患者有26%診斷出貧血。在慢性糖尿病患者中,腎損傷或慢性腎臟病普遍可見全球血紅素檢驗市場,預計2016∼2020年,以年複合成長率10.58%擴大。

本報告提供全球血紅素檢驗市場現狀與2020年的預測,市場規模與銷售趨勢,主要供應商的競爭環境與簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各產品市場區隔

  • 全球血紅素檢查裝置市場
  • 全球血紅素檢驗用試劑及消耗品市場

第7章 各技術市場區隔

  • 層析法
  • 免疫檢測
  • 其他

第8章 各終端用戶市場區隔

  • 實驗室
  • 醫院
  • 研究感測器

第9章 各地區市場區隔

  • 南北美洲
  • 美國的Medicare的償付
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

第11章 促進要素的影響

第12章 市場課題

  • 血紅素檢驗的成本高和維持
  • 嚴格的法律規章問題
  • 替代產品的威脅

第13章 促進要素與課題的影響

第14章 市場趨勢

  • 從中央實驗室轉移到POC檢驗

第15章 供應商環境

  • 競爭模式

第16章 主要供應商簡介

  • Abbott Diagnostics
  • Alere
  • Danaher
  • EKF Diagnostics Holdings
  • Roche Diagnostics
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

目錄
Product Code: IRTNTR9026

About the Hemoglobin Testing Market

The red blood cells in the bloodstream carry a protein known as hemoglobin, which helps to transport oxygen throughout the body. Hemoglobin tests are conducted to detect the quantity of hemoglobin present in the blood. These tests are often done as a part of complete blood count during a routine health check-up or at the time of any illness to determine the type of anemia, which occurs due to low count of red blood cells.

Studies estimated that worldwide around 416 million people were living with diabetes in 2015. Out of which, around 46% of them, i.e., 191.3 million people, were not diagnosed with this disease, owing to lack of awareness. Diabetes and anemia are not directly linked, but studies reveal that around 26% of people with diabetes are diagnosed with anemia. Kidney damage or chronic kidney disease is a common condition observed in people with chronic diabetes.

Technavio's analysts forecast the global hemoglobin testing market to grow at a CAGR of 10.58% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global hemoglobin testing market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of hemoglobin testing equipment and consumables.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Hemoglobin Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Diagnostics
  • Alere
  • Danaher
  • EKF Diagnostics Holdings
  • Roche Diagnostics

Other Prominent Vendors

  • ACON Laboratories
  • ARKRAY
  • Bayer Medical Care
  • Bio-Rad Laboratories
  • Daiichi Biotech
  • DiaSys Diagnostic Systems
  • Diazyme Laboratories
  • Epinex Diagnostics
  • Erba Diagnostics
  • Fisher Scientific
  • GREEN CROSS MEDIS
  • HORIBA
  • HUMAN Gesellschaft fur Biochemica und Diagnostica
  • Masimo
  • Mindray Medical International
  • OrSense
  • PTS Diagnostics
  • Randox Laboratories
  • Sebia
  • Siemens Healthcare
  • Sysmex
  • TaiDoc Technology
  • Tosoh Bioscience
  • Trinity Biotech
  • Una Health

Market driver

  • Development and launch of novel hemoglobin testing devices
  • For a full, detailed list, view our report

Market challenge

  • High cost and maintenance of hemoglobin testing
  • For a full, detailed list, view our report

Market trend

  • Direct-to-consumer testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Invasive method
  • Non-invasive method

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global hemoglobin testing equipment market
  • Global hemoglobin testing reagents and consumables market

PART 07: Market segmentation by technology

  • Chromatography
  • Immunoassay
  • Other

PART 08: Market segmentation by end-user

  • Laboratories
  • Hospitals
  • Research centers

PART 09: Geographical segmentation

  • Hemoglobin testing market in Americas
  • Reimbursement by Medicare in US
  • Hemoglobin testing market in EMEA
  • Hemoglobin testing market in APAC

PART 10: Market drivers

  • Increasing incidence of diabetes and popularity of HbA1c tests
  • Favorable reimbursement of hemoglobin testing
  • Development and launch of novel hemoglobin testing devices

PART 11: Impact of drivers

PART 12: Market challenges

  • High cost and maintenance of hemoglobin testing
  • Stringent regulatory issues
  • Threat of substitute products

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Shift from centralized laboratory to POCT
  • Increased mergers and acquisition (M&A)
  • Direct-to-consumer testing

PART 15: Vendor landscape

  • Competitive scenario

PART 16: Key vendor profiles

  • Abbott Diagnostics
  • Alere
  • Danaher
  • EKF Diagnostics Holdings
  • Roche Diagnostics
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Types of hemoglobin testing methods
  • Exhibit 03: Global hemoglobin testing market 2015-2020 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global hemoglobin testing market segmentation based on product
  • Exhibit 06: Global hemoglobin testing market segmentation based on product 2015
  • Exhibit 07: Global hemoglobin testing market segmentation based on product 2020
  • Exhibit 08: Global hemoglobin testing equipment market 2015
  • Exhibit 09: Global hemoglobin testing equipment market 2020
  • Exhibit 10: Global hemoglobin testing equipment market 2015-2020 ($ millions)
  • Exhibit 11: Global laboratory testing market 2015-2020 ($ millions)
  • Exhibit 12: Global POCT equipment market 2015-2020 ($ millions)
  • Exhibit 13: Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions)
  • Exhibit 14: Segmentation of global hemoglobin testing market by product
  • Exhibit 15: Segmentation of global hemoglobin testing market by product ($ millions)
  • Exhibit 16: Segmentation of global hemoglobin testing market by technology 2015
  • Exhibit 17: Segmentation of global hemoglobin testing market by end-user 2015
  • Exhibit 18: Segmentation of global hemoglobin testing market by geography 2015
  • Exhibit 19: Segmentation of global hemoglobin testing market by geography 2020
  • Exhibit 20: Hemoglobinin testing market in Americas 2015-2020 ($ millions)
  • Exhibit 21: Selected laboratory service with national limitation amount (NLA) provided by Medicare
  • Exhibit 22: Estimation of few diseases in US
  • Exhibit 23: Hemoglobin testing market in EMEA 2015-2020 ($ millions)
  • Exhibit 24: Hemoglobin testing market in APAC 2015-2020 ($ millions)
  • Exhibit 25: Segmentation of global hemoglobin testing market by geography
  • Exhibit 26: Segmentation of global hemoglobin testing market by geography ($ millions)
  • Exhibit 27: Impact of drivers
  • Exhibit 28: Impact of drivers and challenges
  • Exhibit 29: Abbott Diagnostics: Key takeaways
  • Exhibit 30: Alere: Business segmentation by revenue 2014
  • Exhibit 31: Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions)
  • Exhibit 32: Alere: Key takeaways
  • Exhibit 33: Danaher: Key takeaways
  • Exhibit 34: EKF Diagnostics: Business segmentation by revenue 2014
  • Exhibit 35: EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 36: EKF Diagnostics Holdings: Key takeaways
  • Exhibit 37: Roche Diagnostics: Business segmentation by revenue 2015
  • Exhibit 38: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015
  • Exhibit 39: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 40: Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions)
  • Exhibit 41: Roche Diagnostics: Key takeaways
Back to Top